Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2304-2312

  Díaz, G Darío ^a   Paraskeva, Christos ^a   Thomas, Mike G ^b   Binderup, Lise ^c   Hague, Angela ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c LEO PHARMA A S   (Denmark)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL; COLECALCIFEROL DERIVATIVE; SEOCALCITOL;

ADENOMA; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL CYCLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; COLORECTAL TUMOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ALKALINE PHOSPHATASE; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BLOTTING, WESTERN; CALCITRIOL; CELL ADHESION; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; G1 PHASE; GENES, P53; HUMANS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0342803660     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Garland, C. F., Shekelle, R. B., Barrett-Connor, E., Criou, M. H., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium risk of colorectal cancer: a 19-year prospective study in men. Lancet, 1: 307-309, 1985.
2. 3 and the occurrence of colorectal cancer among women. J. Natl. Cancer Inst., 88: 1375-1382, 1996.
3. 3. Carcinogenesis (Lond.). 9: 187-190, 1988.
4. 3. Cancer Res., 47: 21-25, 1987.
5. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis (Lond.). 13: 2293-2298, 1992.
6. Sadava, D., Remer, T., and Petersen, K. Hyperplasia, hyperproliferation and decreased migration rate of colonic epithelial cells in mice fed a diet deficient in vitamin D. Biol. Cell, 87: 113-115, 1996.
7. Giuliano, A. R., Franceschi, R. T., and Wood, R. J. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys., 285: 261-269, 1991.
8. 3. Biochem. Pharmacol., 38: 3859-3865, 1989.
9. Thomas, M. G., Tebbutt, S., and Williamson, R. C. N. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut, 33: 1660-1663, 1992.
10. Welsh, J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol., 72: 537-545, 1994.
11. 3 derivatives on growth, differentiation and apoptosis in tumoral colonie HT-29 cells -possible implication of intracellular calcium. Cancer Lett., 97: 99-106, 1995.
12. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene. 11: 1853-1858, 1995.
13. 3 and its analogue, EB1089, in human breast cancer cells. Oncogene, 15: 1555-1563, 1997.
14. 3 derivative, alone or in association with dexamethasone. Blood, 88: 4659-4666, 1996.
15. 3 induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol., 125: 953-962, 1998.
16. Schrader, M., Bendik, I., Becker-Andre, M., and Carlberg, C. Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem., 268: 17830-17836, 1993.
17. Carlberg, C. RXR-independent action of the receptors for thyroid hormone, retinoid acid and vitamin D on inverted palindromes. Biochem. Biophys. Res. Commun., 195: 1345-1353, 1993.
18. Schrader, M., Muller, K. M., and Carlberg, C. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J. Biol. Chem., 269: 5501-5504, 1994.
19. Berger, U., Wilson, P., McClelland, R. A., Colston, K., Haussler, M. R., Pike, J. W., and Coombes, R. C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J. Clin. Endocrinol. & Metab., 67: 607-613, 1988.
20. 3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res., 51: 1227-1233, 1991.
21. Thomas, M. G., Sylvester, P. A., Newcomb, P., Longman, R. J. Vitamin D receptor expression in colorectal cancer. J. Clin. Pathol., 52: 181-183, 1999.
22. 3. J. Cell. Biochem., 56: 510-517, 1994.
23. Elder, D. J., Hague, A., Hicks, D. J., and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res., 56: 2273-2276, 1996.
24. Paraskeva, C., Buckle, B. G., Sheer, D., and Wigley, C. B. The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer, 34: 49-56, 1984.
25. Paraskeva, C., Finerty, S., Mountford, R. A., and Powell, S. C. Specific cytogenetic abnormalities in two new human colorectal adenoma-derived epithelial cell lines. Cancer Res., 49: 1282-1286, 1989.
26. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumour Cells in Vitro, pp. 115-141. New York: Plenum Press, 1975.
27. Leibovitz, A., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., and Mabry, N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36: 4562-4569, 1976.
28. Williams, A. C., Browne, S. J., Yeudal, W. A., Paterson, I. C., Marshall, C. J., Lane, D. P., and Paraskeva, C. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8: 3063-3072, 1993.
29. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
30. Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci., USA, 87: 7555-7559, 1990.
31. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., and Owen, J. J. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (Lond.), 337: 181-184, 1989.
32. Heerdt, B. G., Houston, M. A., Augenlicht, L. H. Potentiation by specific short chain fatty acids of differentiation and apoptosis in human colonie carcinoma cell lines. Cancer Res., 54: 3288-3293, 1994
33. 1-induced-apoptosis of colorectal adenoma cells is associated with increase expression of the differentiation markers E-cadherin and alkaline phosphatase. Cell Death Differ., 4: 725-732, 1997.
34. Bowers, G. N., and McComb, R. B. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin. Chem., 12: 70-89, 1966.
35. Bradford, M. M. A rapid and sensitive methods for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
36. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonie tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer, Int J Cancer, 55: 498-505, 1993.
37. Bracey, T. S., Miller, J. C., Preece, A., and Paraskeva, C. γ-radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene, 10: 2391-2396, 1995.
38. Arends, M. J., and Wyllie, A. H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol., 32, 223-254, 1991.
39. Hague, A., Diaz, G. D., Hicks, D. J., Krajewski, S., Reed, J. C., and Paraskeva, C. bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int J Cancer, 72: 898-905, 1997.
40. Brehier, A., and Thomasset, M. J. Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D1 receptor and induction of differentiation by the hormone. Steroid Biochem., 29: 265-270, 1988.
41. Zhao, X., and Feldman, D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology, 132: 1808-1814, 1993.
42. 3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Br. J. Pharmacol., 120: 1119-1127, 1997.
43. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp. Cell Res., 209: 367-374, 1993.
44. Krajewskj, S., Krajewska, M., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res., 56: 2849-2855, 1996.
45. 3 analogue shows relation to promoter selectivity. J. Cell. Biochem., 66: 552-562, 1997.
46. Singh, B., and Paraskeva, C. Bcl-2 as a possible sensor of nutritional stress inhibiting apoptosis and allowing cell survival during colorectal carcinogenesis. Biochem. Soc. Trans., 26: 236-241, 1998.